Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Galmed Pharmaceuticals Ltd

GLMD
Current price
0.36 USD -0.053 USD (-12.93%)
Last closed 0.4 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 1 474 914 USD
Yield for 12 month +23.10 %
Week
Month
Year
GLMD
21.11.2021 - 28.11.2021

Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinical trial with HIV-associated non-alcoholic fatty liver disease and lipodystrophy. In addition, it engages in the development of Amilo-5MER, a 5 amino acid synthetic peptide methionine, threonine, alanine, aspartic acid, and valine. It has a license agreement with Samil Pharma. Co., Ltd. for the commercialization of Aramchol in the Republic of Korea; and a collaboration agreement with OnKai for its AI platform. Galmed Pharmaceuticals Ltd. was founded in 2000 and is headquartered in Tel Aviv, Israel. Address: 16 Tiomkin Street, Tel Aviv, Israel, 6578317

Analytics

WallStreet Target Price

1 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

Key Figures GLMD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -7 756 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -25.29 %
PEG Ratio
Return On Equity TTM -48.15 %
Wall Street Target Price 1 USD
Revenue TTM
Book Value 3.88 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings Share -3.02 USD
Diluted Eps TTM -3.02 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics GLMD

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History GLMD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:15
Payout Ratio
Last Split Date 15.05.2023
Dividend Date

Stock Valuation GLMD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA 1.5272
Price Book MRQ 0.0944

Financials GLMD

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators GLMD

For 52 weeks

0.26 USD 14.18 USD
50 Day MA 0.42 USD
Shares Short Prior Month 10 970
200 Day MA 1.24 USD
Short Ratio 0.39
Shares Short 12 845
Short Percent 0.34 %